ExodusPoint Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $904K | Buy |
|
|||||
|
2024
Q3 | $649K | Sell |
|
|||||
|
2024
Q2 | $1.14M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $692K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $995K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $719K | Buy |
|
|||||
|
2021
Q3 | $877K | Sell |
|
|||||
|
2021
Q2 | $956K | Sell |
|
|||||
|
2021
Q1 | $903K | Buy |
|
|||||
|
2020
Q4 | $468K | Sell |
|
|||||
|
2020
Q3 | $2.15M | Buy |
|
|||||
|
2020
Q2 | $1.21M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $191K | Buy |
|